
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.360 | 0.480 | 0.120 |
Stocks | 99.640 | 99.640 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 25.088 | 17.094 |
Price to Book | 4.779 | 2.624 |
Price to Sales | 3.205 | 1.918 |
Price to Cash Flow | 15.787 | 11.381 |
Dividend Yield | 0.514 | 2.177 |
5 Years Earnings Growth | 11.451 | 12.400 |
Name | Net % | Category Average |
---|---|---|
Technology | 39.410 | 20.984 |
Industrials | 31.130 | 17.000 |
Healthcare | 24.160 | 13.405 |
Consumer Cyclical | 3.560 | 10.904 |
Financial Services | 1.750 | 12.971 |
Number of long holdings: 71
Number of short holdings: 9
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Intuitive Surgical | US46120E6023 | 2.92 | 491.81 | -0.05% | |
Cyberark Software | IL0011334468 | 2.91 | 346.76 | -0.46% | |
Fair Isaac | US3032501047 | 2.87 | 1,853.46 | -1.04% | |
Cloudflare | US18915M1071 | 2.83 | 117.94 | +0.31% | |
Verisk | US92345Y1064 | 2.82 | 287.68 | -0.71% | |
Fortinet | US34959E1091 | 2.73 | 98.45 | +0.29% | |
Halma | GB0004052071 | 2.65 | 2,673.0 | +0.07% | |
CrowdStrike Holdings | US22788C1053 | 2.62 | 369.03 | -1.61% | |
Thermo Fisher Scientific | US8835561023 | 2.62 | 518.64 | +0.04% | |
Experian | GB00B19NLV48 | 2.59 | 3,616.0 | +2.76% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Global Security Equity Fund B USD | 2.25B | 7.91 | 8.67 | 11.07 | ||
Global Security Equity Fund IB USD | 2.25B | 7.97 | 9.43 | 11.96 | ||
CS Lux Digital Health Equity IB | 798.91M | -5.86 | -12.94 | - | ||
LU1683287707 | 798.91M | -5.82 | -12.90 | - | ||
LU1683285164 | 798.91M | -6.52 | -13.54 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review